HOLLI BEALL: Open Payments
NPI 1700175106 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 16 payments from 8 companies in 2025. Trend: 2023 $297 · 2024 $174 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $153 |
| Ardelyx, Inc. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
| OPKO Pharmaceuticals, LLC | 1 | $16 |
Products named: KRYSTEXXA, IBSRELA, JARDIANCE, FARXIGA, AREXVY, JYNARQUE, TARPEYO, RAYALDEE.
Industry payments across AL — which companies pay providers there.
